Arthritis Clinical Trials in New York

60 recruiting studies across 1 city

Browse by City

All Trials in New York

Phase

Trial	Phase	Sponsor	Dist.
Nipocalimab in Moderate to Severe Sjogren's Disease	Phase 3	Janssen Research & Development, LLC	<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	<1 mi
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer	Phase 1	National Cancer Institute (NCI)	<1 mi
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis	Phase 2	Eli Lilly and Company	<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	<1 mi
Navio Robotic Versus Conventional Total Knee Arthroplasty	N/A	Columbia University	<1 mi
MOTION Clinical Trial	N/A	Moximed	<1 mi
Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy	N/A	Hospital for Special Surgery, New York	<1 mi
Multi-Center PAMPA Study	Phase 4	NYU Langone Health	<1 mi
Oral Steroid Taper After Total Knee Arthroplasty	Phase 1	Columbia University	<1 mi
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients	Phase 3	University of Pennsylvania	<1 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.	Phase 3	Paradigm Biopharmaceuticals Ltd.	<1 mi
Exactech Shoulder Post Market Clinical Follow-up Study	—	Exactech	<1 mi
Persona MC vs PS RCT With ROSA	N/A	NYU Langone Health	<1 mi
A Long-term Extension Study of Ustekinumab in Pediatric Participants	Phase 3	Janssen Research & Development, LLC	<1 mi
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee	Phase 1/2	Britecyte	<1 mi
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis	N/A	Hospital for Special Surgery, New York	<1 mi
Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis	Phase 2/3	NYU Langone Health	<1 mi
Return to Golf After Orthopaedic Surgery	—	Hospital for Special Surgery, New York	<1 mi
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)	—	Zimmer Biomet	<1 mi
Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty	N/A	JointMedica Inc.	<1 mi
Oral Nutritional Optimization in Total Joint Arthroplasty	N/A	NYU Langone Health	<1 mi
RA-PRO PRAGMATIC TRIAL	Phase 3	University of Alabama at Birmingham	<1 mi
Chronic Pain in Rheumatoid Arthritis	—	Northwestern University	<1 mi
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare	Phase 2/3	Olatec Therapeutics LLC	<1 mi
The KinematX Midcarpal Total Wrist Arthroplasty Registry	—	Extremity Medical	<1 mi
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout	Phase 4	Massachusetts General Hospital	<1 mi
Preventing Injured Knees From osteoArthritis: Severity Outcomes	Phase 2	Brigham and Women's Hospital	<1 mi
Primary Subtalar Arthrodesis for Calcaneal Fractures	N/A	Wake Forest University Health Sciences	<1 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis	Early 1	R3 Medical Research	<1 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain	Phase 1	R3 Stem Cell	<1 mi
Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being	N/A	Weill Medical College of Cornell University	<1 mi
Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis	—	Hospital for Special Surgery, New York	<1 mi
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies	—	Weill Medical College of Cornell University	<1 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	<1 mi
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases	Phase 2	Amgen	<1 mi
A Study of AZD0120 in Autoimmune Diseases	Phase 1	AstraZeneca	<1 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight	Phase 3	Eli Lilly and Company	4 mi
Innovations in Genicular Outcomes Registry	—	Pacira Pharmaceuticals, Inc	4 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines	Phase 3	Takeda	5 mi
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee	Phase 2	Pacira Pharmaceuticals, Inc	5 mi
Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis	N/A	University of Pennsylvania	5 mi
ConsideRAte Study - Splenic Stimulation for RA	N/A	Galvani Bioelectronics	5 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	5 mi
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))	N/A	DePuy Orthopaedics	12 mi
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis	Phase 3	Duke University	12 mi
Ultralow Dose PET Imaging for 18F-NaF Uptake	Phase 2	Akiva Mintz	13 mi
Focused Extracorporeal Shockwave Therapy for Knee Arthritis	N/A	Kessler Foundation	14 mi
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis	Phase 3	Bristol-Myers Squibb	17 mi
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy	N/A	Northwell Health	17 mi
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome	Phase 3	Bristol-Myers Squibb	19 mi
Stronger Together Psoriatic Arthritis Wellness Study	—	Global Healthy Living Foundation	28 mi
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.	Phase 3	AbbVie	28 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab	Phase 3	AbbVie	28 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee	Phase 3	Eli Lilly and Company	29 mi
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis	Phase 3	Sun Pharmaceutical Industries Limited	30 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)	Phase 3	Amgen	30 mi
Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis	Phase 2	ZetrOZ, Inc.	34 mi
Persona Revision Knee System Outcomes	—	Zimmer Biomet	37 mi
Randomized Placebo Controlled Study of Triamcinolone Acetonide Extended Release Injection for Thumb (CMC) Osteoarthritis	Phase 2	Marie Badalamente	48 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.